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Protein degradation: De-ubiquitinate to decide your fate
Daniel Kalderon
The ubiquitination/de-ubiquitination system that
controls the degradation of many cellular proteins can
be regulated at several of its distinct steps; one recently
discovered control is important in Drosophila eye
development.
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The covalent attachment of ubiquitin to proteins can act as
a signal for their degradation by a multisubunit complex
known as the 26S proteasome [1]. A combination of in vitro
reconstitution studies and mutational analyses in yeast has
identified many of the enzymes responsible for ubiquitina-
tion, and provided evidence for essential roles of this
pathway in the proteolysis of damaged or mis-folded
proteins, as well as in determining the high turn-over rate
of naturally short-lived proteins. The large diversity of
potential ubiquitination substrates presents a challenge to
the recognition mechanism that is, in some cases, comp-
ounded by the need to regulate protein stability according
to the cell cycle or environmental cues. 
One possible solution to this problem would be for many
substrates to share common degradation signals, but for
their efficacy to be altered by substrate modifications such
as phosphorylation or denaturation. Alternatively, the
diversity of ubiquitinating enzymes may accommodate
recognition of many different signals; in this case, the
degradation of a single protein, or a small group of prot-
eins, could be regulated according to the activity of a spec-
ific ubiquitinating enzyme. Whether de-ubiquitinating
enzymes contribute to the regulation of protein degrada-
tion has remained speculative in the absence of demon-
strated substrate specificity. However, recent studies by
Fischer-Vize and colleagues [2] have now provided an
example in which loss of function of a de-ubiquitinating
enzyme is associated with a specific developmental pheno-
type, prompting a re-examination of how regulation and
specificity are achieved in ubiquitin-mediated events.
Enzymology of ubiquitination
The ubiquitin pathway of protein degradation involves
several steps catalysed by distinct enzymes (Fig. 1). Ubiq-
uitin is a 76-amino-acid protein that is generated either by
proteolysis of newly-synthesized polyproteins or by recy-
cling ubiquitin molecules that have been linked to other
proteins post-translationally. Free ubiquitin is activated by
an ‘E1’ enzyme forming a thiol-ester between the carboxyl
terminus of ubiquitin and a cysteine residue of E1, and is
Figure 1
The ubiquitin-dependent protein degradation pathway. Free ubiquitin
molecules — generated from polyprotein precursors or protein
conjugates degraded by the proteasome — are linked to target proteins
by the action of E1, E2 and E3 enzymes. Multi-ubiquitination may be
processive or interrupted and continued by the same or different E2/E3
enzymes. De-ubiquitinating enzymes (UBPs) can reverse the downward
path toward degradation by the proteasome at any time, and mono-
ubiquitinated proteins may be particularly accessible to recognition by
substrate-specific de-ubiquitinating enzymes. Degradation of a protein
may be modulated by ubiquitin concentration, changes in substrate
conformation — induced, for example, by binding partners,
phosphorylation or denaturation — that affect specific recognition
signals, steric hindrance or flexibility, or by changes in activity of specific
enzymes that catalyze ubiquitination or de-ubiquitination.
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subsequently transferred to a cysteine residue of one of
several ‘E2’ ubiquitin-conjugating enzymes. In vitro, some
E2 enzymes directly catalyze the formation of an isopep-
tide bond between the carboxyl terminus of ubiquitin and
the e-NH2 group of an internal lysine residue of a protein
substrate, whereas others require the participation of an
‘E3’ enzyme, often known as a ubiquitin ligase. 
The best-characterized E3 enzyme, E6-AP, forms a
ubiquitin–thiol-ester intermediate, but some other E3
enzymes may act simply by simultaneous binding of an E2
enzyme and a substrate molecule. Most commonly, only a
single or small number of lysine residues of a substrate are
ubiquitinated. However, multiple ubiquitin molecules are
frequently conjugated to a single protein molecule by
sequential attachment to an internal lysine (usually K48)
of a ubiquitin molecule already linked to the substrate.
Multi-ubiquitination increases affinity for the proteasome
and is essential for protein degradation in vivo.
Recognition of ubiquitination signals
What are the primary recognition signals for protein ubiq-
uitination and how are they recognized by E2/E3
enzymes? Experiments with model substrates defined the
‘N-end rule’ signal, where several destabilizing amino-
terminal residues are recognized by a specific E3 enzyme
(UBR1 in yeast). Few substrates appear to rely on this
signal in vivo, however, as loss of UBR1 function in yeast
eliminates degradation of model ‘N-end rule’ substrates
without phenotypic consequence or a measurable effect
on protein turnover. 
A hypothetical degradation signal that is also potentially
simple enough to be shared by many proteins is a ‘PEST’
sequence, a region rich in amino acids proline (P), gluta-
mate (E), serine (S) and threonine (T) that is found at
particularly high frequency in proteins with short half-
lives. Transferrable ubiquitination/degradation signals
have been identified within PEST regions of yeast
proteins GCN4 and CLN3 [3] but, as yet, no specific
consensus sequence has been found, nor has an E2 or E3
enzyme been identified that recognizes these sequences
with high affinity. The paucity of obvious sequence simil-
arity among the (few) degradation signals identified to
date (in B-type cyclins, Jun, Mos, CLN3, GCN4 and
MATa2) suggests the existence of a large number of
structurally distinct recognition determinants, likely to
exceed by far the number of E2 enzymes. 
The current inventory of twelve E2 enzymes (UBC1-12)
in yeast is likely to be fairly complete, because they are
readily identified by sequence similarity over a 150-
amino-acid domain and by their shared ability to be recipi-
ents of ubiquitin from E1 enzymes. The implication that a
single E2 enzyme would have to recognize multiple subst-
rates directly or by interaction with different E3 proteins
is confirmed by studies with ubc2 mutant yeast [4]. UBC2 is
required for normal sporulation, DNA repair (hence the
gene’s alternative name RAD6) and ‘N-end rule’ substrate
degradation, but these activities are selectively dependent
on UBR1 function (‘N-end rule’ degradation only) and the
intact carboxyl terminus of UBC2 (both sporulation and ‘N-
end rule’ degradation), suggesting that UBC2 functionally
interacts with at least three different proteins.
The diversity of E3 proteins in a cell is hard to assess at
present, as the two cloned prototypes, UBR1 and E6-AP,
are not related in sequence, and the biochemical mecha-
nism by which E3 promotes ubiquitination by E2
enzymes has not been well defined. The identification of
at least ten human proteins that share sequences — ‘hect’
domains — around the catalytically active cysteine of E6-
AP [5] suggests that the E3 family may be quite large, ear-
marking E3 enzymes as the principal key to substrate
specificity. Combinatorial recognition of substrates by
pairs of E2 and E3 enzymes has been suggested, but
neither E6-AP nor UBR1 require E2 enzymes for target
binding in vitro.
Multi-ubiquitination
The attachment of a single ubiquitin molecule is not nec-
essarily a one-way ticket to Palookaville. In vitro, some
E2/E3 enzymes catalyze processive multi-ubiquitination,
whereas others (usually E2 alone) favor the attachment of
one or a small number of ubiquitins, conceivably because
multimeric E2/E3 complexes encourage processivity. If
E2/E3 enzymes also dissociate from mono-ubiquitinated
substrates in vivo, this would provide an ideal opportunity
for a substrate-specific de-ubiquitinating enzyme to act in
the absence of steric hindrance from bound E2/E3
enzymes or a large branched chain of ubiquitins.
Mono-ubiquitinated intermediates may be recognized by
E2/E3 enzymes that are not specific to the particular sub-
strate, as it is known that covalent linkage of ubiquitin to a
stable model protein suffices as a signal for further ubiqui-
tination and degradation in vivo, by a mechanism that
requires yeast UBC4 activity [6]. If UBC4 (and the related
UBC5 and UBC1) are commonly used for extending
ubiquitin chains that were initiated by other enzymes, this
could explain the widespread effects of mutations of
UBC4 family genes on the half-lives of most short-lived
and abnormal proteins.
Protein degradation
The 26S proteasome includes a 20S catalytic core which
forms a hollow cylinder lined with the active sites of prot-
eases of various specificities, and a 19S particle which
forms an ante-chamber to the narrow (1.3 nm) entrance of
the 20S cylinder [7]. Binding of multi-ubiquitin to subunit
5 of the 19S particle targets proteins to the proteasome,
where they are assumed to be unfolded by ATPases in
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order to gain entrance into the 20S cylinder where they are
cleaved into oligopeptides. Although entry into the protea-
some normally signals the end of a protein’s unique contri-
bution to the cell, there are some important exceptions.
The cleavage of cellular antigens prior to presentation by
class I major histocompatibility complex (MHC) mole-
cules appears to involve the proteasome, and indeed the
cleavage specificity can be modified by cytokine-induced
changes in the representation of particular protease sub-
units. The proteasome can also catalyse partial proteolysis,
for example degrading only the carboxyl terminus of the
primary NF-kB translation product, p105, to leave an
intact and functional p50 fragment. It is not known if this
domain of the protein is spared because it cannot be
unfolded, because it is firmly anchored in the 19S particle
by ubiquitinated residues or for some other reason.
Regulation of ubiquitination
An emerging characteristic of ubiquitin-mediated degra-
dation is that it is a regulatable process. For all proteins,
misfolding and random or thermal denaturation are impor-
tant autonomous signals for degradation. This may allow
formation of a novel structure that acts as a specific degra-
dation signal. Studies with model substrates, however,
suggest that introduction of flexibility — for example, by
addition of an unstructured ‘linker’ or reduction of disul-
phide bonds — can greatly enhance the recognition of a
pre-existing degradation signal. E2/E3 enzymes may be
designed to demand substrate flexibility for optimal
binding, or flexibility may enhance access of bound E2/E3
enzymes to internal lysine residues of the substrate. In
similar fashion, proteins that cannot bind their usual cellu-
lar partners, because of denaturation, mutation or regula-
tion, may be particularly prone to E2/E3 recognition
simply from the absence of steric hindrance. Such sub-
strate-mediated cues can be supplemented in response to
general signals such as heat-shock by the induction of
ubiquitination components that also act generally, such as
the multi-ubiquitin protein and UBC4/UBC5 enzymes.
But what of more specific signals that are designed to
affect the ubiquitination of only single or a small number
of proteins? These signals must impinge either on the
substrate directly or on components of the ubiquitin
pathway that are selective in their action. Such enzymes
need not be rigorously substrate-specific — they may be
like the several protein kinases that are known to trans-
duce a signal through a specific substrate, while also
enhancing the phosphorylation of other proteins without
detrimental effects. 
For ubiquitination, there is evidence for both types of
regulation in response to cell-cycle cues. An E3-contain-
ing complex, known as the cyclosome, promotes ubiquiti-
nation of cyclin B in vitro only if isolated from late
M-phase extracts of Spisula (clam) embryos or Xenopus
eggs. The complex can be inactivated by an okadaic-acid-
sensitive phosphatase and re-activated by cyclin-depen-
dent kinase phosphorylation [8]. By contrast, the effects
of cyclin-dependent kinase activity on promoting the
ubiquitin-mediated degradation of a G1 cyclin, CLN3, in
yeast appear to be mediated, at least in part, by phospho-
rylation of a specific residue of CLN3 embedded in a
PEST sequence that can act as a transferrable degradation
signal [3].
The regulation of ubiquitination by signal-induced sub-
strate phosphorylation may be quite widespread.
Autophosphorylation of Mos at serine 3 occurs during the
latter stages of Xenopus oocyte maturation, and appears to
be essential for stabilization against ubiquitin-mediated
degradation. Conversely, Ik-Ba — a negative regulator of
NFkB that sequesters the transcription factor in the
cytoplasm — undergoes signal-dependent phosphoryla-
tion at serines 32 and 36 as an essential pre-requisite for
subsequent ubiquitination and proteasome-mediated
degradation. 
Activation of Ik-Ba phosphorylation by a partially purified
700 kD protein kinase complex in vitro requires the addi-
tion of ubiquitin, E1 and a catalytically active E2 enzyme
of the UBC4 class, the same E2 enzyme that subsequently
participates in the ubiquitination of phosphorylated Ik-Ba
in vitro [9]. The ubiquitination target is not known, but
the proteasome does not participate in the activation
event. Thus, an apparently straightforward instance of
regulation of ubiquitination by substrate modification may
yet be overturned in favor of a ubiquitination enzyme as
the primary focus of regulation. This example, and the
ligand-induced ubiquitination and subsequent endocyto-
sis of STE2, the yeast a-factor receptor, which again
appears to depend on phosphorylation [10], also empha-
size that ubiquitination need not serve only as a tag for
binding to the proteasome.
De-ubiquitination
So where do de-ubiquitinating enzymes come in?
Although a large number of these enzymes (at least 15 in
yeast) have been identified biochemically or by sequence
motifs, mutational phenotypes in yeast and direct bio-
chemical characterization have so far provided little evid-
ence of substrate specificity. Some of these enzymes can
only cleave ubiquitin from precursor-like fusion proteins,
but several also have isopeptidase activity that in one case
(isopeptidase T) recognizes only free multi-ubiquitin
chains, but which more often can act on either multi-ubiq-
uitinated or mono-ubiquitinated proteins without strict
specificity toward the non-ubiquitin moiety.
Four of the first five yeast de-ubiquitinating enzymes to
be identified can be mutated simultaneously without
obvious effects on ubiquitin-mediated protein degradation
or other phenotypes [11]. Mutations in the fifth protease,
DOA4, do impair growth but, perhaps counter-intuitively,
they reduce degradation of model substrates [12]. The
DOA4 protease appears to be required for cleavage of
ubiquitin from short peptides during the final steps of
protein degradation and it was postulated that accumula-
tion of unprocessed peptide conjugates impairs access of
protein–ubiquitin conjugates to the proteasome. This
argument can be extended to the generalization that
proteasome-bound de-ubiquitinating enzymes are likely
to have unique functions by virtue of their localization,
whereas soluble cytosolic enzymes may have redundant
functions unless they have distinct substrate specificities.
Enter fat facets.
The Drosophila Fat facets protein shows similarity to other
de-ubiquitinating enzymes in two small regions surround-
ing critical cysteine and histidine residues, and can cleave
a model ubiquitin fusion protein in Escherichia coli [2]. Site-
directed mutation of the critical cysteine and histidine
residues showed that this activity was essential to its
normal function in Drosophila. In the absence of fat facets
(faf) function, flies survive to adulthood but their eyes
develop abnormally, incorporating supernumerary cells
that undergo neuronal differentiation into each ommatidial
cluster. Also, adult females are infertile. 
In contrast to the loss of DOA4 in yeast, loss of Fat facets
in Drosophila is suggested to promote protein degradation,
as the rough-eye phenotype is partially suppressed by
reducing the dosage of a proteasome component. The sim-
plest interpretation of these results is that Fat facets norm-
ally prevents a specific protein from entering the
degradation pathway. If so, one might wonder if Fat facets
simply returns the putative substrate to its original state, by
removing its ubiquitin tag, or whether the substrate is mod-
ified by its experience, perhaps retaining some particular
configuration of ubiquitin residues that alter its activity
without demanding its degradation.
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